Cognition Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | 11.5% | 11.5% | -110.1% |
| FY2021 | -22.9% | -22.9% | -19.8% |
| FY2022 | -53.2% | -53.2% | -42.4% |
| FY2023 | -105.4% | -105.4% | -73.3% |
| FY2024 | -181.2% | -181.2% | -112.4% |
| FY2025 | -68.5% | -68.5% | -48.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | 11.5% | 11.5% | -110.1% |
| FY2021 | -22.9% | -22.9% | -19.8% |
| FY2022 | -53.2% | -53.2% | -42.4% |
| FY2023 | -105.4% | -105.4% | -73.3% |
| FY2024 | -181.2% | -181.2% | -112.4% |
| FY2025 | -68.5% | -68.5% | -48.5% |